US 11911385
Methotrexate treatment methods
granted A61KA61K31/519A61K47/10
Quick answer
US patent 11911385 (Methotrexate treatment methods) held by Aldeyra Therapeutics, Inc. expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/519, A61K47/10, A61K47/26, A61K9/0019